Characterizing inhibitors of nANGPTL4 to restore LPL activity for treating hypertriglyceridemia and related cardiovascular diseases.
Unlocking the Therapeutic Potential of ANGPTL4: From Molecular Complexity to Clinical Insight
Accelerate your metabolic and oncology drug discovery pipelines! Are you currently facing challenges in validating the complex, context-dependent roles of ANGPTL4 in metabolic disorders, cancer progression, and angiogenesis? Our ANGPTL4 Analysis Services leverage a suite of advanced molecular and cellular profiling technologies to help you elucidate its proteolytic processing, receptor interactions, and downstream signaling pathways, providing the critical functional data needed to develop targeted therapeutics and biomarkers.
Overview of ANGPTL4 Analysis
ANGPTL4 is a multifaceted protein implicated in lipid metabolism, cancer biology, and angiogenesis. Its full-length form can be cleaved into N-terminal and C-terminal domains, which exhibit distinct and sometimes opposing biological activities. Comprehensive analysis must therefore delineate these forms, their interactions, and functional outcomes. Our service integrates orthogonal methodologies to map ANGPTL4's proteolytic landscape, binding affinities, and cellular effects, transforming complex biology into actionable data.
| Technical Method | Core Principle | Primary Application in ANGPTL4 Analysis |
|---|---|---|
| Proteomic Profiling (WB/MS) | Immunoblotting & Mass Spectrometry | Identification and quantification of full-length vs. cleaved ANGPTL4 forms. |
| Surface Plasmon Resonance (SPR) | Real-time biomolecular interaction analysis | Kinetic characterization of ANGPTL4 binding to receptors or inhibitors. |
| Lipoprotein Lipase (LPL) Activity Assay | Enzymatic fluorescence/colorimetry | Functional assessment of nANGPTL4-mediated LPL inhibition. |
| Cell-based Migration/Invasion Assay | Transwell/Boyden chamber systems | Evaluation of cANGPTL4 effects on tumor cell motility and angiogenesis. |
| qPCR/RNA-Seq | Gene expression quantification | Profiling ANGPTL4 expression and its impact on downstream signaling pathways. |
Fig.1 Structure of ANGPTL4.Distributed under CC BY-SA 4.0, from Wiki,
without modification.
How Creative Biolabs' Service Can Assist Your Project?
Creative Biolabs provides an end-to-end analytical framework to deconvolute the ANGPTL4 puzzle. We deliver not just data, but a comprehensive biological narrative that clarifies whether your therapeutic candidate effectively modulates the intended ANGPTL4 form and pathway. Our solutions address key R&D hurdles, including distinguishing between proteolytic variants, quantifying functional inhibition in physiologically relevant systems, and validating target engagement in complex cellular models.
Discover How We Can Support You – Begin a Consultation Request.
Service Workflow
Our structured workflow ensures rigorous, reproducible analysis at every stage, from sample preparation to final reporting.
01Project Scoping & Sample Intake
Define project goals and collect starting materials, including ANGPTL4 protein, cell lines, or biological samples.
02Form-Specific Characterization
Identify and quantify ANGPTL4 cleavage products through proteomic analysis and buffer optimization for stability.
03Biophysical & Functional Interaction Analysis
Perform SPR and functional assays to measure binding kinetics and biological activity like LPL inhibition or cell migration.
04Downstream Pathway Elucidation
Map signaling consequences by profiling the gene expression of downstream targets like VEGF and MMPs.
05Data Integration & Reporting
Correlate all datasets to link molecular forms with binding affinity, functional output, and pathway modulation.
06Final Deliverables
Provide a comprehensive analytical report featuring kinetic parameters, IC50 values, and strategic project interpretations.
Applications
Fig.2 Cross-talk possibilities between lipid and glucose metabolism in oncogenesis.1
Our ANGPTL4 Analysis Services empower research and development across multiple critical fields:
Metabolic Disease Therapeutics
Oncology & Anti-Angiogenesis Drug Development
Evaluating the impact of cANGPTL4 blockers or mimetics on tumor metastasis, angiogenesis, and chemoresistance in relevant cancer models.
Biomarker Discovery & Validation
Quantifying specific ANGPTL4 proteoforms in patient serum or tissue as prognostic or diagnostic biomarkers for cancer or metabolic syndrome.
Mechanism of Action Studies
Defining whether a drug candidate acts by altering ANGPTL4 cleavage, blocking receptor engagement, or modulating downstream transcriptional programs.
Biosimilar & Biotherapeutic Characterization
Profiling the functional equivalence of therapeutic proteins that may interact with or modulate the ANGPTL4 pathway.
Published Data
Fig.3 The protein levels of ANGPTL4 in NP tissues across various IVDD grades as determined by western blot analysis.2
A pivotal study underscores the necessity for form-specific analysis. Researchers demonstrated that while full-length ANGPTL4 inhibited endothelial cell migration, its cANGPTL4 fragment potently stimulated it. This stark functional dichotomy was linked to differential activation of signaling pathways. Our service directly addresses this complexity, employing targeted assays to distinguish between such opposing activities, ensuring your therapeutic strategy is based on precise molecular mechanisms, not aggregate protein measurements.
Why Choose Us?
Choosing Creative Biolabs for your ANGPTL4 analysis means partnering with specialists who understand its biological nuances.
- Form-Specific Expertise: Specializing in discriminating and quantifying proteolytic variants (nANGPTL4 vs. cANGPTL4) to provide biologically relevant data rather than just measuring total protein levels.
- Integrated Functional-Biophysical Platform: Combining proteomics, SPR kinetics, and cell-based functional assays to provide a 360-degree view of ANGPTL4 activity from the molecular level to the cellular phenotype.
- Pathway-Centric Analysis: Moving beyond simple binding events to elucidate downstream transcriptional and phenotypic consequences, directly linking target engagement to biological outcomes.
- Proven Success in Challenging Targets: Utilizing a track record of published data and project history in characterizing complex, multifunctional proteins like ANGPTL4 to ensure reliable results for high-stakes projects.
Uncover the Creative Biolabs Advantage - Obtain a Quote Today.
Frequently Asked Questions
-
Q: Why is it crucial to analyze different cleaved forms of ANGPTL4 separately?
A: The full-length, N-terminal, and C-terminal fragments of ANGPTL4 have distinct, often opposing, biological functions. Aggregate measurement can mask these critical differences, leading to misleading conclusions. Our service is specifically designed to isolate and characterize these individual forms.
-
Q: Can you help identify which receptor my ANGPTL4 variant is binding to?
A: Absolutely. Using SPR and cell-based binding assays with specific blocking antibodies or ligands, we can profile and quantify ANGPTL4 interactions with various putative receptors to identify the primary engagement partners.
-
Q: What sample types are suitable for your ANGPTL4 analysis?
A: We can analyze purified recombinant proteins, cell culture supernatants, tissue lysates, and serum samples. The optimal sample type depends on your specific research question, which we can discuss during project scoping.
-
Q: Do you offer services for screening compound libraries against ANGPTL4 activity?
A: Yes. We have established high-throughput compatible formats for key functional assays, such as LPL inhibition, which can be leveraged for primary or secondary screening of compound libraries.
-
Q: How do your services support IND-enabling studies?
A: We provide the rigorous, quantitative, and orthogonal data packages on target engagement, mechanism of action, and biomarker correlation that are essential for robust regulatory filings. Our reports are designed to meet the stringent documentation requirements for preclinical development.
| Cat | Service |
| BAS88-1 | ANGPTL4 Protein Analysis |
| BAS88-2 | ANGPTL4 mRNA Analysis |
| BAS88-3 | Establishment of ANGPTL4-overexpressing Cells |
| BAS88-4 | ANGPTL4 Knockdown Assay |
| BAS88-5 | ANGPTL4 Aptamers Screening |
| BAS88-6 | Aptasensor Development |
| BAS88-7 | ANGPTL-XXX Interaction Assay |
Contact Us
Creative Biolabs stands as a premier provider of specialized ANGPTL4 Analysis Services. Our integrated platform, combining deep biological insight with cutting-edge analytical technologies, delivers the precise, form-specific, and functionally relevant data you need to confidently advance your metabolic and oncology research programs. For detailed technical discussions, custom project proposals, or a specific quote, please reach out to our expert scientific team.
References
- La Paglia, Laura, et al. "Potential role of ANGPTL4 in the cross talk between metabolism and cancer through PPAR signaling pathway." PPAR research 2017 (2017). Distributed under CC BY-SA 4.0, without modification. Doi: https://doi.org/10.1155/2017/8187235
- Braune, Katarina, Ines Volkmer, and Martin S. Staege. "Characterization of Alstrom syndrome 1 (ALMS1) transcript variants in Hodgkin lymphoma cells." PLoS One 12.1 (2017): e0170694. Distributed under Open Access license CC BY 4.0, without modification. Doi: https://doi.org/10.1371/journal.pone.0170694.
For Research Use Only.